Shaw and Partners is pleased to be appointed as Lead Manager to the proposed equity capital raising by BrainChip Holdings Limited (ASX.BRN)

BrainChip is proposing to issue up to 262.4 million new shares at an issue price of A$0.06 per share to raise up to $15.7 million (assuming fully subscribed). 

The raising will be by way of a 1 for 4 accelerated non-renounceable entitlement offer comprising an institutional entitlement offer and a retail entitlement offer.

The issue price represents: a 36.2% discount to last close of A$0.094 as at 24 June 2019 and a 31.2% discount to TERP of A$0.087 as at 24 June 2019

The offer is available to Australian and New Zealand resident Sophisticated and Professional Investor clients only.

For more information please contact your Shaw and Partners Adviser.

About BrainChip

BrainChip Holdings (BRN) is the global leader in the commercialisation of autonomous learning technology, Spiking Neural Networks (“SNN”), that can simulate the learning methods of the human brain. The Company’s software and hardware solutions address the high-performance requirements in civil surveillance, gaming, facial recognition and visual inspection systems, and BRN has deployed its products globally to government and institutional clients. BRN’s patented intellectual property protects its technology and market position.